The department for Clinical Neurosciences and Preventive Medicine is engaged in a variety of clinical trials including pure academic trials and others sponsored by pharmaceutical industry. The special situation of having an office at the Neurological Department of the Donauklinikum Tulln opens the opportunity to involve medical specialists and physicians during their training in those trials. This allows both sides to profit from the synergetic potential between the Danube University and the Donauklinikum.
RESPECT ESUS Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
This international, randomized, double-blind, event-driven, multi-centre trial tests the effect of dabigatran (110 mg or 150 mg twice daily) compared to acetylsalicyclic acid (100 mg once daily) for the secondary prevention of stroke in patients with recent embolic stroke of unknown source.